Current Treatment Options and Future Treatment Options: Addressing the Unmet Needs in Treating UTUC

Jennifer A. Linehan, MD, is a board-certified urologist with expertise in robot-assisted laparoscopic surgery for kidney, bladder, and prostate cancers. She is an Associate Professor of Urology and Urologic Oncology at the John Wayne Cancer Institute in Santa Monica, California. She completed her urologic residency at the University of Arizona Medical Center in Tucson, where she received the Van Winkle Award for Excellence in Surgical Research and the Drach Award for Most Compassionate Resident. She then completed a two-year Robotic Surgery Fellowship in Urologic Oncology at City of Hope in Los Angeles. Recently, Dr. Linehan has been dedicating her research efforts to focus on the diagnosis and monitoring of both upper tract urothelial carcinoma and kidney cancer through urine cfNA. For this research, Linehan and her team at the John Wayne Cancer Institute are developing a novel technique. Dr. Linehan has several active clinical trials for urothelial carcinoma, including OLYMPUS and OPTIMA II, as well as another with a focus on 3D imaging during robotic partial nephrectomy. Dr. Linehan is a member of the American Urologic Association and the Society of Urologic Oncologists, and is a leader of Young NARUS (North American Robotic Urologic Surgeons).